Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
MRC CIC - Discovery of small molecule MO25-binders as novel treatments for resistant hypertension
Mehellou, Youcef
(Principal Investigator)
Alderwick, Luke
(Co-Investigator)
Martin, Una
(Co-Investigator)
Simpkins, Nigel
(Co-Investigator)
Pharmacy
Biosciences
Chemistry
Clinical Sciences
Overview
Fingerprint
Research output
(1)
Research output
Research output per year
2018
2018
2018
1
Article
Research output per year
Research output per year
1 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Search results
2018
The Photosensitizing Clinical Agent Verteporfin is an Inhibitor of SPAK and OSR1 Kinases
Alderwick, L.
&
Jeeves, M.
,
12 Jul 2018
, (E-pub ahead of print)
In:
ChemBioChem.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Verteporfin
100%
Photosensitizing Agents
63%
Phosphotransferases
41%
Blood Pressure
27%
Ions
17%
9
Citations (Scopus)
179
Downloads (Pure)